Myocardial Infarction Flashcards
What is an infarction?
What is a myocardial infarction?
What is the metabolic reason this ocurs?
- Infarction
- the process by which necrosis (cell or tissue death) results from ischemia (loss of blood supply)
- Myocardial Infarction
- infarction of cardiac muscle
- etiology: lack of oxygen and various metabolits due to blockage of blood flow
What is the major causes of myocardial infarction?
- Atherosclerosis is major cause for MI
- Others
- coronary embolism
- congenital coronary anomaly
- coronary trauma
- coronary spasm
- drug use (cocaine)
- other factors (increase oxygen requirement)
- heavy exertion, fever, hyperthyroidism, or strong emotions
The heart utilizes what types of molecules as fuel?
It is is most likely to use what type of molecule in the experience of ischemia?
carbohydrates, amino acids, and fatty acids
During ischemia: high glucose utilization
Myocardial utilization of what types of fuels is concentration dependent?
lactate and fatty acids
Decrease in coronary blood flow increases what process?
What is the purpose of this?
glycolysis
-
Purpose: return the normal contractile function of the heart
- via glucose oxidation & glycogen resynthesis
- translocation of GLUT4 to the plasma membrane in situations of acute ischemia
Why do we see an elevation of free fatty acids in the plasma ater a MI?
- surge of catecholamin activity
- inhibition fo beta oxidation of lipids in mitochondria
- accumulation of intracellular acyl carnitine and acylcoenzyme A
In what situations do we see reduced myocardial uptake of free fatty acids during ischemia?
high glucose concentration
What is the reasoning behing the Glucose, insulin & potassium (GIK) treatment for a MI?
How effective is it?
- If the injury zone of infarction has a low membrane resting polarization, the intracellular potassium is proportionately decreased, if [K] outside the fiber remains constant
- the treatment with GIK forces potassium into the cell, thus restoring the normal resting potential
- Effectiveness
- A reduction of 28% in mortality
- even in patients who had received thrombolytic agents, the in-hospital death rate was reduced by over 60%
What is the concern with administering GIK treatment?
fear of myocardial acidosis as a result of increased lactate production
also, the research wasn’t supported b/c not profitable
What is the effect of increased NO in the infarcted myocardium?
How is the majority of NO produced?
What end-products increase in the blood following MI/coronary artery occlusion?
- Released primarily through inducible form of NO synthase (iNOS)
-
NO + Guanylate cyclase-heme-Fe –> cGMP
- NO binds to the heme group of Guanylate cycyase
- increase in cGMP produces the physiological & pharmacological effects
-
NO + Guanylate cyclase-heme-Fe –> cGMP
- Helps contratcile and metabolic functions of the infarcted heart
- necessary for the growth-promoting effect of vascular endothelial growth factor (VEGF) – important for develping collaterl arteries
- End products
- NO2 (nitrite)
- NO3 (nitrate)
- peroxynitrite & hydroxy-like intermediates
There is an increase in what 3 biological substances within the infarcted myocardium?
NO, prostacyclin, and thromboxane
What is the function of prostacyclin & thromboxane in
- Prostacyclin
- inhibit platelet aggregation
- coronary vasodilation
- prevents ventricular arrhythmias
- decreases infarct size
- Thromboxane
- promotes platelet aggregation
- causes vasoconstriction
- initiates ventricular arrhythmias
- increases infarct size
- increases production of NO and prostacyclin counteracts these effects
What is the relationship between NO and the COX systems?
NO synthase & cyclooxygenase (COX) form prostanoids from arachidonic acid
cross-talk between the systems – production of NO increases production of prostacyclin & thromboxane
How do the NSAIDs, Aspirin & celecoxib, influence NO, prostacyclin & thromboxane?
- acetylsalicylic acid (Aspirin), a COX1 and -2 (75mg/kg/day) inhibitor, reduces both prostaglandin & thromboxane formation
- does not influencemyocardial activity of iNOS
-
celecoxib, a COX2 selective inhibitor lowers myocardial prostacyclin production
- does not alter myocardial production of nitrit & nitrate
What cardiac biomarker levels are assessed for diagnosis of MI?
cardiac troponin
sensitive & accurate